13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q2 2023 · Filed April 27, 2023 · Accession 0000950123-23-003438
Total Value
$233.4M
Positions
6
Other Managers
1
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $76.9M | 32.93% |
| 2 | VAXCYTE INC | PCVX | 1,457,300 | $54.6M | 23.40% |
| 3 | MERUS N V | N5749R100 | 1,600,000 | $29.4M | 12.61% |
| 4 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $28.2M | 12.09% |
| 5 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,000,000 | $26.5M | 11.36% |
| 6 | PHATHOM PHARMACEUTICALS INC | PHAT | 2,484,274 | $17.7M | 7.60% |